SCHEDULE 13G: Armistice Capital and Steven Boyd Disclose 5.59% Stake in Bicycle Therapeutics PLC

Investment firm Armistice Capital, LLC and its managing member Steven Boyd have disclosed a passive 5.59% beneficial ownership stake in Bicycle Therapeutics PLC, totaling 2,672,000 American Depositary Shares.

Summary

• Armistice Capital, LLC and Steven Boyd (collectively, the "Reporting Persons") have reported beneficial ownership of 2,672,000 American Depositary Shares (ADS) of Bicycle Therapeutics PLC.
• This ownership represents 5.59% of the total outstanding shares of Bicycle Therapeutics PLC.
• The shares are held by Armistice Capital Master Fund Ltd., with Armistice Capital, LLC acting as the investment manager and exercising voting and investment power.
• Steven Boyd, as the managing member of Armistice Capital, is also deemed to beneficially own these securities.
• The filing indicates that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
• The percentage of shares is based on 47,761,845 shares outstanding as of April 28, 2025, as reported in Bicycle Therapeutics PLC's Form 10-Q filed on May 1, 2025.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the issuer's performance or prospects.

Future Outlook

NA

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional ownership stake, which can be viewed as a vote of confidence or simply a disclosure of a passive investment.
• Management: Awareness of a significant shareholder, though the filing states no intent to influence control.

Key Dates

Keywords

Bicycle Therapeutics PLC, Armistice Capital, Steven Boyd, Schedule 13G, Beneficial Ownership, ADS, American Depositary Shares, Investment Management, Biotechnology, Pharmaceuticals